No subject

John Wynne johnwynne at csi.com
Wed Aug 13 11:32:25 BRT 1997


Does anyone have any experience or knowledge of the company CORIXA. They 
are developing vaccines and diagnostics based on antigens and adjuvants to 
stimulate T-cells in Leishmaniasis (and T. cruzii).

Any information or opinions you can share about the technology, company or 
opportunity would be most helpful. Thank you.





More information about the Leish-l mailing list